Rare hemorrhagic disorder due to a qualitative platelet defect

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:275736
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare hemorrhagic disorder due to a qualitative platelet defect is a broad grouping category on Orphanet (ORPHA:275736) that encompasses a collection of inherited bleeding disorders in which platelets are present in normal or near-normal numbers but do not function properly. Unlike quantitative platelet disorders where platelet counts are reduced, these qualitative defects involve abnormalities in platelet adhesion, activation, aggregation, or secretion. The primary body system affected is the hemostatic (blood clotting) system, leading to a tendency for excessive or prolonged bleeding. Patients with qualitative platelet defects typically present with mucocutaneous bleeding symptoms, which may include easy bruising (ecchymoses), prolonged bleeding from cuts or surgical procedures, nosebleeds (epistaxis), heavy menstrual bleeding (menorrhagia) in women, gum bleeding, and in more severe cases, gastrointestinal bleeding or postpartum hemorrhage. The severity of bleeding can range from mild to life-threatening depending on the specific underlying molecular defect. Symptoms may be present from early childhood or may only become apparent when the hemostatic system is challenged, such as during surgery or trauma. This category includes well-characterized conditions such as Glanzmann thrombasthenia (a defect in platelet aggregation due to GPIIb/IIIa abnormalities), Bernard-Soulier syndrome (a defect in platelet adhesion due to GPIb-IX-V complex abnormalities), and various platelet storage pool deficiencies and signal transduction defects. Treatment is largely supportive and depends on the specific disorder, but may include platelet transfusions for severe bleeding episodes, desmopressin (DDAVP) for mild defects, antifibrinolytic agents such as tranexamic acid, and recombinant activated factor VII (rFVIIa) in refractory cases. Avoidance of antiplatelet medications such as aspirin and NSAIDs is generally recommended. Genetic counseling is important for affected families.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare hemorrhagic disorder due to a qualitative platelet defect.

View clinical trials →

No actively recruiting trials found for Rare hemorrhagic disorder due to a qualitative platelet defect at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare hemorrhagic disorder due to a qualitative platelet defect community →

No specialists are currently listed for Rare hemorrhagic disorder due to a qualitative platelet defect.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare hemorrhagic disorder due to a qualitative platelet defect.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare hemorrhagic disorder due to a qualitative platelet defectForum →

No community posts yet. Be the first to share your experience with Rare hemorrhagic disorder due to a qualitative platelet defect.

Start the conversation →

Latest news about Rare hemorrhagic disorder due to a qualitative platelet defect

No recent news articles for Rare hemorrhagic disorder due to a qualitative platelet defect.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rare hemorrhagic disorder due to a qualitative platelet defect

What is Rare hemorrhagic disorder due to a qualitative platelet defect?

Rare hemorrhagic disorder due to a qualitative platelet defect is a broad grouping category on Orphanet (ORPHA:275736) that encompasses a collection of inherited bleeding disorders in which platelets are present in normal or near-normal numbers but do not function properly. Unlike quantitative platelet disorders where platelet counts are reduced, these qualitative defects involve abnormalities in platelet adhesion, activation, aggregation, or secretion. The primary body system affected is the hemostatic (blood clotting) system, leading to a tendency for excessive or prolonged bleeding. Patien